Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2350154 | 0.87 | NR4A2 (0.50) | NR4A2POLBALDH1A1USP2LMNA | |
| SCHEMBL3416860 | 0.86 | NR4A2 (0.53) | NR4A2POLBALDH1A1USP2LMNA | |
| SCHEMBL8500052 | 0.85 | NR4A2 (0.51) | NR4A2POLBALDH1A1USP2LMNA | |
| SCHEMBL9283137 | 0.83 | NR4A2 (0.45) | NR4A2POLBALDH1A1USP2LMNA | |
| SCHEMBL28034933 | 0.82 | NR4A2 (0.49) | NR4A2POLBALDH1A1LMNAHTT | |
| SCHEMBL29386752 | 0.81 | CREBBP (0.50) | POLBSLC22A6ALDH1A1HTTMITF | |
| SCHEMBL1051164 | 0.81 | CREBBP (0.50) | POLBSLC22A6ALDH1A1HTTMITF | |
| SCHEMBL28095904 | 0.81 | NR4A2 (0.48) | NR4A2POLBALDH1A1LMNAMITF | |
| SCHEMBL28034324 | 0.79 | NR4A2 (0.56) | NR4A2POLBSLC22A6ALDH1A1LMNA | |
| SCHEMBL7431522 | 0.79 | NR4A2 (0.56) | NR4A2SLC22A6ALDH1A1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120004784-A | New method for preparing aromatic aldehyde compound | 广东海洋大学 | 2025-05-16 | — | — | CN | disclosed |
| CN-115286625-B | Glutaminase allosteric site covalent inhibitor and preparation method and application thereof | 浙江工业大学 | 2025-03-25 | — | — | CN | disclosed |
| US-20240272148-A1 | METHOD OF STABILIZING MOLECULES WITHOUT REFRIGERATION USING WATER SOLUBLE POLYMERS AND APPLICATIONS THEREOF IN PERFORMING CHEMICAL REACTIONS | MCMASTER UNIVERSITY (CA) | 2024-08-15 | — | — | US | disclosed |
| US-11940444-B2 | Method of stabilizing molecules without refrigeration using water soluble polymers and applications thereof in performing chemical reactions | MCMASTER UNIVERSITY (CA) | 2024-03-26 | — | — | US | disclosed |
| CN-115286625-A | Glutaminase allosteric site covalent inhibitor and preparation method and application thereof | 浙江工业大学 | 2022-11-04 | — | — | CN | disclosed |
| US-20210088518-A1 | DETECTING MICROBIAL INFECTION IN WOUNDS | SYNOVO GMBH (DE) | 2021-03-25 | — | — | US | disclosed |
| CN-109053630-A | A kind of benzothiazole analog derivative and application thereof | 中国人民解放军第二军医大学 | 2018-12-21 | — | — | CN | disclosed |
| CN-102482234-B | Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation | OTSUKA PHARMACEUTICAL CO.,LTD. (JP) | 2016-04-13 | — | — | CN | disclosed |
| CN-104936591-A | Erythropoietin expression promoter | UNIV TOHOKU NAT UNIV CORP | 2015-09-23 | — | — | CN | disclosed |
| CN-103382206-A | Quinoline or quinazoline derivative, its preparation method and application in medicines | SHANGHAI HENGRUI PHARM CO LTD | 2013-11-06 | — | — | CN | disclosed |
| CN-101291924-A | Isoindole-imide compounds and compositions comprising and methods of using the same | CELGENE CORP (US) | 2008-10-22 | — | — | CN | disclosed |
| CN-1972920-A | Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms | WYETH CORP (US) | 2007-05-30 | — | — | CN | disclosed |
| CN-1897946-A | 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms | WYETH CORP (US) | 2007-01-17 | — | — | CN | disclosed |
| CN-1894226-A | Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use | WYETH CORP (US) | 2007-01-10 | — | — | CN | disclosed |
| CN-1671726-A | 3-descladinosyl-6-O-carbamoyl and 6-O-alkoxycarbonyl macrolide antibacterial agents | JANSSEN PHARMACEUTICA NV (BE) | 2005-09-21 | — | — | CN | disclosed |
| CN-1197860-C | FAB I inhibitors | SMITHKLINE BEECHAM CORP (CA) | 2005-04-20 | — | — | CN | disclosed |
| CN-1558897-A | oral antidiabetic agent | ����-�����ع�˾ | 2004-12-29 | — | — | CN | disclosed |
| CN-1378542-A | Antigen binding fragment I inhibitors | SMITHKLINE BEECHAM CORP (US) | 2002-11-06 | — | — | CN | disclosed |
| CN-1088853-C | Silver halide light sensitive emulsion layer having enhanced photographic sensitivity | EASTMAN KODAK CO (US) | 2002-08-07 | — | — | CN | disclosed |
| EP-0268429-A2 | Photoinitiator composition | MORTON INTERNATIONAL, INC. (US) | 1988-05-25 | — | — | EP | disclosed |